Ticker: BSPM, Company: Biostar Pharmaceuticals, Inc., Type: 10-K, Date: 2010-03-31
Original SEC Filing: Click here

---

Webplus: BSPM/20100331/10-K/1/000.htm SEC Original: biostar10k123109.htm
FORM 10-K x For the fiscal year ended December31, 2009 OR o to For the transition period from 333-147363 BIOSTAR PHARMACEUTICALS, Maryland 20-5101287 (State or other jurisdiction oforporation or organization) (I.R.S. Employer Identification No.) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province The Peoples Republic of China 712046 (Zipde)

---

---

Webplus: BSPM/20100331/10-K/2_EX-10.27/000.htm SEC Original: ex10-27.htm
Wu Quan Mountain Land Use Transferreement Party A: Villagemmittee of the Wu Quan Village, Jiang Cun Town, Huunty (Transferor) Party B: Shaanxi Aoxing Pharmaceutical (Transferee) I. Party A shall transfer the land use right to Party B of a land sized 9,000 Mou, east border at the center of Shi He, west border at the

---

---

Webplus: BSPM/20100331/10-K/3_EX-31.1/000.htm SEC Original: ex31-1.htm
SECTION 302 OF THERBANES-OXLEY ACT OF 2002 I, Ronghua Wang, certify that: 1. I have reviewed this annual report on Form 10-K of Biostar Pharmaceuticals,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in

---

---

Webplus: BSPM/20100331/10-K/4_EX-31.2/000.htm SEC Original: ex31-2.htm
SECTION 302 OF THERBANES-OXLEY ACT OF 2002 I, Elaine Zhao, certify that: 1. I have reviewed this annual report on Form 10-K of Biostar Pharmaceuticals,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in

---

---

Webplus: BSPM/20100331/10-K/5_EX-32.1/000.htm SEC Original: ex32-1.htm
18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2)The informationntained in the Report fairly presents, inl material respects, the financialndition and result of operations of thempany at thetes and for the periods indicated. Ronghua Wang Chief Executive Officer March 31, 2010 ex32-1.htm

---

---

Webplus: BSPM/20100331/10-K/6_EX-32.2/000.htm SEC Original: ex32-2.htm
18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2)The informationntained in the Report fairly presents, inl material respects, the financialndition and result of operations of thempany at thetes and for the periods indicated. Elaine Zhao Chief Financial Officer March 31, 2010 ex32-2.htm

---

Company Information:

Ticker: BSPM, Company: Biostar Pharmaceuticals, Inc., Type: 10-K, Date: 2010-03-31CIK: 0001418133, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
NO. 588 SHIJI XI AVENUE
XIANYANG, SHAANXI PROVINCE 712046